Tag
Hannah Joseph Hospital Limited
5 articles
Hannah Joseph Hospital Limited's recent financial disclosures highlight a period of robust growth and strategic expansion. The company reported a significant 55% increase in net profit for FY26, alongside an 18.73% rise in revenue, driven by its established leadership in neurosciences and trauma care. A maiden final dividend of ₹2 per share, representing a 20% payout, underscores the company’s commitment to shareholder returns following a successful SME IPO that raised ₹42 crore. Future plans include expanding into oncology services and establishing a pharmacy & lab branch, while a recent on-market share purchase by the promoter signals continued confidence in the company’s prospects.
Hannah Joseph Hospital FY26 Net Profit Up 55%
Hannah Joseph Hospital Limited submitted its Annual Report for FY 2025-26 to BSE, disclosing a 55% YoY increase in net profit to ₹1,118.12 lakhs.
The Board recommended a maiden final dividend of ₹2 pe
Hannah Joseph Hospital 15th AGM Notice and FY26 Results
Hannah Joseph Hospital Limited convened its 15th Annual General Meeting on July 15, 2026, to approve audited financial statements and declare a final dividend of ₹2 per share.
FY26 financial performan
Hannah Joseph Hospital Investor Presentation FY26
Hannah Joseph Hospital submits its FY26 investor presentation to BSE, confirming it contains no UPSI.
The 133-bed hospital reported FY26 revenue of ₹92.05 Cr, PAT of ₹11.18 Cr, and an EPS of ₹6.32.
St
Hannah Joseph Hospital Declares 20% Final Dividend
Hannah Joseph Hospital intimated BSE about its 15th Annual General Meeting scheduled for July 15, 2026.
Board recommended final dividend of ₹2 per share (20% on face value) for FY 2025-26, subject to
Hannah Joseph Hospital Promoter Buys 3.84 Lakh Shares
Dr. Mosesjoseph Arunkumar, Promoter & MD, acquired 3,84,000 equity shares of Hannah Joseph Hospital Limited on 27.03.2026.
The acquisition was made on-market via BSE at a total transaction value of ₹2